Uncontrolled Wet AMD: Drug Switch Can Mute Disease Activity

Phase 3 data from the 2023 ARVO meeting showed treatment with the monoclonal antibody improved visual acuity in some patients.
Medscape Medical News

source https://www.medscape.com/viewarticle/991143?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

Heart Failure Care Outside of ICU Can Lower Cost